TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biopotent AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
4,865
|
4,433
|
6,588 |
| Financial expenses |
46
|
0
|
0 |
| Earnings before taxes |
360
|
463
|
632 |
| EBITDA |
760
|
740
|
901 |
| Total assets |
3,038
|
3,560
|
2,732 |
| Current assets |
1,824
|
1,989
|
2,470 |
| Current liabilities |
1,022
|
1,358
|
1,143 |
| Equity capital |
1,501
|
1,457
|
1,322 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
49.4%
|
40.9%
|
48.4% |
| Turnover per employee |
2,432
|
2,216
|
3,294 |
| Profit as a percentage of turnover |
7.4%
|
10.4%
|
9.6% |
| Return on assets (ROA) |
13.4%
|
13.0%
|
23.1% |
| Current ratio |
178.5%
|
146.5%
|
216.1% |
| Return on equity (ROE) |
24.0%
|
31.8%
|
47.8% |
| Change turnover |
432
|
-2,155
|
444 |
| Change turnover % |
10%
|
-33%
|
7% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.